LINC00525 promotes tumour growth and epithelial‐mesenchymal transition as an oncogene in oral squamous cell carcinoma
Oral Diseases · 2024
DOI: 10.1111/odi.14613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Juan Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Epithelial-Mesenchymal Transition, RNA, Long Noncoding, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Oral squamous cell carcinoma (OSCC) is the most common malignant tumour in the oral cavity. OSCC is aggressive and prone to metastasis; it is associated with high mortality and short survival. In this study, we investigated the function of the long non‐coding RNA LINC00525 in OSCC progression and the molecular mechanisms through in vitro and in vivo experiments. Materials and Methods CCK8 assay was used to detect the effect of LINC00525 on cell viability; transwell migration and invasion assays and scratch assay were used to examine the role of LINC00525 in cell migration and invasion. Flow cytometry, RT‐PCR and western blot were used to detect apoptosis indexes. Tumorigenic effects were investigated using mouse xenograft tumour models.
Results
LINC00525 was associated with OSCC survival and prognosis. LINC00525 knockdown decreased cell viability and epithelial‐mesenchymal transition (EMT) properties and increased apoptosis and also shortened the cell cycle of OSCC cells in vitro. The downregulation of LINC00525 reduced the growth of OSCC tumour in vivo. LINC00525 can regulate OSCC cells via the apoptotic signalling pathway.
Conclusion
Our results indicate that LINC00525 exhibits oncogenic functions in OSCC. LINC00525 may be a new promising and potential target for the treatment of OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Förderung
- National Nature Science Foundation of China
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Du, J., Su, W., Li, X., Zu, T., Bai, J., Zhang, W., & Zhou, W. (2024). LINC00525 promotes tumour growth and epithelial‐mesenchymal transition as an oncogene in oral squamous cell carcinoma. Oral Diseases. https://doi.org/10.1111/odi.14613
Vancouver
Du J, Su W, Li X, Zu T, Bai J, Zhang W, et al. LINC00525 promotes tumour growth and epithelial‐mesenchymal transition as an oncogene in oral squamous cell carcinoma. Oral Diseases. 2024. doi:10.1111/odi.14613
BibTeX
@article{Du2024,
author = {Du, Juan and Su, Wenjing and Li, Xiaoguang and Zu, Tingjian and Bai, Jinbo and Zhang, Weidong and Zhou, Wei},
title = {LINC00525 promotes tumour growth and epithelial‐mesenchymal transition as an oncogene in oral squamous cell carcinoma},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14613}
}
EUVIMED